ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1837

Enhanced Mitochondrial Activity in B cells from Females Is Required to Drive Increased T-bet Induction by TLR7 in Lupus

John D. Mountz1, Kathryn Sullivan2, Shanrun Liu2, Cynthia Liu2, Min Gao2, Walter Winn Chatham3, Tanecia Mitchell2 and Hui-Chen Hsu2, 1University Alabama Birmingham, Birmingham, AL, 2University of Alabama at Birmingham, Birmingham, AL, 3University of Nevada, Las Vegas, Las Vegas, NV

Meeting: ACR Convergence 2025

Keywords: B-Cell Targets, gender, Mitochondrial Dysfunction, Mouse Models, Lupus, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (1830–1854) Systemic Lupus Erythematosus – Etiology and Pathogenesis Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Systemic lupus erythematosus (SLE) is a predominantly female autoimmune disease, with a 9:1 female-to-male ratio. Our previous studies indicated that increased T-bet+ age-related B cells (ABCs) was associated with elevated circulating type I interferon (IFN) and autoantibody development in female, but not male, lupus prone BXD2 mice. While dysregulated type I IFN signaling and Toll-like receptor 7 (TLR7) activation are established contributors to SLE, the molecular mechanisms underlying sex-specific immune responses in mice and humans are not fully understood.

Methods: The transcriptomic profiles of naïve B cells (IGHM+IGHD+IGHG-) from 11 female (5 SLE patients and 6 healthy) and 11 male donors (4 autoimmune inflammatory disease patients [AID] and 7 healthy) were analyzed by single cell-RNA sequencing analysis. B-cell response induced by R848 (TLR7 agonist) plus IFNβ in vitro was analyzed for early activation of CD69 at 4h and T-bet at 24h, respectively, using B cells derived from female and male BXD2 mice. Real-time PCR was used to determine if R848 plus IFNβ impacts the expression of mitochondrial electron transport chain (ETC) complex I genes, Ndufa1 and Ndufa3. Mitochondrial oxidative phosphorylation (OxPhos) was measured using the Mitochondrial Stress Test and Seahorse Analyzer at 48 and 72h. Flow cytometry was used to evaluate the impact of the complex I inhibitor IM-156 on R848 plus IFNβ-induced T-bet and GL7 upregulation at 72h.

Results: Increased IFN-stimulated genes was the primary transcriptomic signature in female SLE patient B cells. B cells from females, regardless of health status and ethnicity, exhibited elevated expression of mitochondrial ETC genes, including complex I genes compared to males. Regarding mice, there was similar early activation of CD69 at 4h and T-bet expression at 24h in B cells from both sexes. However, B cells from female mice exhibited significantly higher expression of Ndufa1 and Ndufa3 at 24h and 72h. There was a significant increase in basal and maximal respiration, ATP production, and reserve capacity in B cells from female mice at 48h and 72h. This was associated with significantly increased development of T-bet+GL7+ B cells in female mice at 72h. In vitro pharmacologic inhibition of complex I with IM-156 significantly attenuated T-bet upregulation in B cells of female mice.

Conclusion: These findings suggest that the development of T-bet⁺ B cells in female BXD2 mice is strongly dependent on increased mitochondrial OxPhos. Sex-biased differences in OxPhos may therefore act as an intrinsic factor, making it more likely for precursor B cells to reach the energy thresholds needed for differentiation into ABCs under TLR7 and type I IFN stimulation in females with lupus.


Disclosures: J. Mountz: None; K. Sullivan: None; S. Liu: None; C. Liu: None; M. Gao: None; W. Chatham: Sobi, 2; T. Mitchell: None; H. Hsu: None.

To cite this abstract in AMA style:

Mountz J, Sullivan K, Liu S, Liu C, Gao M, Chatham W, Mitchell T, Hsu H. Enhanced Mitochondrial Activity in B cells from Females Is Required to Drive Increased T-bet Induction by TLR7 in Lupus [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/enhanced-mitochondrial-activity-in-b-cells-from-females-is-required-to-drive-increased-t-bet-induction-by-tlr7-in-lupus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/enhanced-mitochondrial-activity-in-b-cells-from-females-is-required-to-drive-increased-t-bet-induction-by-tlr7-in-lupus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology